U-Neuron Biomedical Inc carries a market capitalization of 1.29B, placing it among publicly traded companies globally.
| Market Cap | 1.29B |
| Enterprise Value | N/A |
U-Neuron Biomedical Inc's stock has declined approximately -1.03397% over the past 52 weeks. The 50-day moving average sits at 33.81, while the 200-day moving average is 37.52.
| Beta (5Y) | N/A |
| 52-Week Price Change | -1.03397% |
| 50-Day Moving Average | 33.81 |
| 200-Day Moving Average | 37.52 |
| Average Volume (20 Days) | N/A |
U-Neuron Biomedical Inc's most recent stock split took place on June 20, 2024 with a 500:533 split ratio.
| Last Split Date | 6/20/2024 |
| Split Ratio | 500:533 |